Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

Associate Professor in Microvascular Medicine, Rebecca Foster, explores therapeutic approaches to improve kidney health for ...

Researchers are urging more study into whether a surgical procedure called LVA may be repurposed as a potential Alzheimer's ...

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the risk of ...

Diagnosing heart failure usually involves several tests. Doctors may use blood tests, imaging scans, or ultrasound of the ...